StockMacro
Company, fund or insider

Help

Menu

Covista

$109.13 -12% in 6 monthsMarket cap $3.6B

CVSA on XNYS, Services, Covista Inc., job postings

Measures activity, not value. Not investment advice.

Quarterly revenue rose 11% to $511.5M while capital spending jumped 135% to $37.6M.

  • BadShort interest 8.5% of shares, 8.2 days to cover

Written by AI from the data on this page, 21 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Covista Inc is America's healthcare educator across five accredited institutions: Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. It delivers education to its students at multiple campuses and online. Its segments are Chamberlain, Walden, and Medical and Veterinary. Walden generates maximum revenue and includes the operations of Walden, which offers degree and certificate programs, including those in nursing, education, counseling, business, information technology, psychology, public health, social work and human services, public administration and public policy, and criminal justice. The Company generates maximum revenue from Domestic operations.

Industry
Services-educational services (Services)
Employees
5,037
Website
covista.com
Listed
NYSE, US
Last results
29 Oct 2026
Next results
expected around 27 Jan 2027 (an estimate: a year ago it reported on 28 Jan 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $511.5M, net income $67.4M.
Quarter to 31 Dec 2021: revenue $371.2M, net income $17.9MQuarter to 31 Dec 2021: revenue $371.2M, net income $17.9MQuarter to 31 Mar 2022: revenue $365.6M, net income $349.8MQuarter to 31 Mar 2022: revenue $365.6M, net income $349.8MQuarter to 30 Jun 2022: revenue $361.2M, net income $8.0MQuarter to 30 Jun 2022: revenue $361.2M, net income $8.0MQuarter to 30 Sep 2022: revenue $354.6M, net income $2.2MQuarter to 30 Sep 2022: revenue $354.6M, net income $2.2MQuarter to 31 Dec 2022: revenue $363.3M, net income $24.1MQuarter to 31 Dec 2022: revenue $363.3M, net income $24.1MQuarter to 31 Mar 2023: revenue $369.1M, net income $45.9MQuarter to 31 Mar 2023: revenue $369.1M, net income $45.9MQuarter to 30 Sep 2023: revenue $368.8M, net income $10.6MQuarter to 30 Sep 2023: revenue $368.8M, net income $10.6MQuarter to 31 Dec 2023: revenue $393.2M, net income $39.9MQuarter to 31 Dec 2023: revenue $393.2M, net income $39.9MQuarter to 31 Mar 2024: revenue $412.7M, net income $36.8MQuarter to 31 Mar 2024: revenue $412.7M, net income $36.8MQuarter to 30 Jun 2024: revenue $409.9M, net income –Quarter to 30 Sep 2024: revenue $417.4M, net income $46.2MQuarter to 30 Sep 2024: revenue $417.4M, net income $46.2MQuarter to 31 Dec 2024: revenue $447.7M, net income $75.9MQuarter to 31 Dec 2024: revenue $447.7M, net income $75.9MQuarter to 31 Mar 2025: revenue $466.1M, net income $60.8MQuarter to 31 Mar 2025: revenue $466.1M, net income $60.8MQuarter to 30 Jun 2025: revenue $457.1M, net income $54.2MQuarter to 30 Jun 2025: revenue $457.1M, net income $54.2MQuarter to 30 Sep 2025: revenue $462.3M, net income $61.8MQuarter to 30 Sep 2025: revenue $462.3M, net income $61.8MQuarter to 31 Dec 2025: revenue $503.4M, net income $76.4MQuarter to 31 Dec 2025: revenue $503.4M, net income $76.4MQuarter to 31 Mar 2026: revenue $487.0M, net income $41.6MQuarter to 31 Mar 2026: revenue $487.0M, net income $41.6MQuarter to 30 Jun 2026: revenue $501.4M, net income $71.7MQuarter to 30 Jun 2026: revenue $501.4M, net income $71.7MQuarter to 30 Sep 2026: revenue $511.5M, net income $67.4MQuarter to 30 Sep 2026: revenue $511.5M, net income $67.4M
31 Dec 2021RevenueNet incometallest bar $511.5M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$511.5M$67.4M
30 Jun 2026$501.4M$71.7M
31 Mar 2026$487.0M$41.6M
31 Dec 2025$503.4M$76.4M
30 Sep 2025$462.3M$61.8M
30 Jun 2025$457.1M$54.2M
31 Mar 2025$466.1M$60.8M
31 Dec 2024$447.7M$75.9M
30 Sep 2024$417.4M$46.2M
30 Jun 2024$409.9M–
31 Mar 2024$412.7M$36.8M
31 Dec 2023$393.2M$39.9M
30 Sep 2023$368.8M$10.6M
31 Mar 2023$369.1M$45.9M
31 Dec 2022$363.3M$24.1M
30 Sep 2022$354.6M$2.2M
30 Jun 2022$361.2M$8.0M
31 Mar 2022$365.6M$349.8M
31 Dec 2021$371.2M$17.9M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $2.0B $1.8B
Revenue growthRevenue of the last 12 months compared with the 12 months before. +9.3% +2.9%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $257.2M $252.7M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). $7.31 $6.68
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 57.4% 57.1% 56.2%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. 19.8% 19.5% 9.2%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. 12.8% 13.8% 6.8%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. 17.9% 15.8%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. $354.6M $323.2M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $222.2M $264.7M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $500.2M $553.2M
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). $278.0M $288.5M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.35 0.21
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $42.75
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 14.1 12.9
P/SPrice to sales: market cap divided by revenue of the last 12 months. 1.8 1.1
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 2.0 1.0
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 2.6 2.1

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
CovistaCVSA (this company) $3.6B14.11.8+9.3%12.8%
StrideLRN $3.1B9.41.2+2.5%13.2%
Laureate EducationLAUR $4.4B11.22.3+21%20.3%
Grand Canyon EducationLOPE $2.8B11.02.4+5.3%21.9%
GrahamGHC $5.2B10.5–––
Perdoceo EducationPRDO $1.7B9.42.0+6.4%21.1%

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+11%

$511.5M vs $462.3M (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

+135%

$37.6M vs $16.0M (quarter ended 30 Sep 2026)

Insider buy/sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$1.3M

bought $0, sold $1.3M

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+4.3%

385 13F filers vs 369

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

over 100%

33.9M shares held by 13F filers (30 Sep 2026) of 33.3M outstanding (23 Oct 2026); above 100%: the share count is probably stale

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

8.5%

2.8M shares sold short (30 Oct 2026) of 33.3M outstanding (23 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

8.2

2.8M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

+1.4%

2.8M shares sold short in the report before, 2.8M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

83%

83% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 63%

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

$42K

the 12 months before: $28K

Lobbying What the company reported spending on federal lobbying over the last four quarters.

$740K

4 quarters

News Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

10

10 articles in the last 7 days; its usual week has 1 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

10×

10 articles in the last 7 days; its usual week has 1.

Unusual now sharp changes in the last 90 days, compared with its own past

  • Capital spending $37.6M, 2.3× a year earlier

Price $109.13 on 20 Nov 2026, +9.6% over 12 months (12-month range $96.07 to $140.98)

  • Sharp change
  • 8-K and other filings
  • Lobbying filing
Insider net buying (open market). Insiders sold a net $6.6M in the last 12 months (the 12 months before: -$9.7M).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 8 published in the last 12 months (none in the 12 months before).
Revenue per quarter. Revenue $511.5M in the latest quarter, +11% on a year earlier.
Capital spending per quarter. Capital spending $37.6M in the latest quarter, +135% on a year earlier.
Institutional holders (13F filers). 385 13F filers reported holding it in the latest 13F quarter, +1.3% on a year earlier.
Federal obligations. Federal obligations: $68K published in the last 12 months, +37% on the 12 months before.
Lobbying spend. Lobbying spend: $740K published in the last 12 months, -53% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
3 Nov 2026Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 37.6M vs usual 16.3M (2026-09-30); 2.3x the same period a year earlier
28 Jul 20268-K and other filingsDirector or officer change
28 Jul 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
21 Jul 2026Lobbying filinglobbying engagement terminated (ALPINE GROUP PARTNERS, LLC.)
20 Jul 2026Lobbying filinglobbying engagement terminated (FEROX STRATEGIES)
3 Mar 20268-K and other filingsA major agreement ended
30 Jun 2025Lobbying filingnew lobbying registration (FEROX STRATEGIES)
19 Nov 20248-K and other filingsDirector or officer change
19 Nov 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
22 Oct 2024Sharp changeLobbying spend jump: lobbying spend jump, 530K vs usual 130K (2024-09-30); 1.8x the same period a year earlier
28 Jun 2024Lobbying filingnew lobbying registration (ALPINE GROUP PARTNERS, LLC.)
7 May 2024Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 21.7M vs usual 7.8M (2024-03-31); 2.3x the same period a year earlier
9 Jan 20248-K and other filingsDirector or officer change
9 Jan 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
24 Oct 2023Sharp changeLobbying spend jump: lobbying spend jump, 300K vs usual 105K (2023-09-30); 2.5x the same period a year earlier
6 Sep 20238-K and other filingsDirector or officer change
6 Sep 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
5 Sep 2023Lobbying filingnew lobbying registration (THEGROUP DC, LLC)
20 Apr 2023Sharp changeLobbying on a new issue: lobbying on a new issue: AGR (2023-03-31)
14 Nov 20228-K and other filingsDirector or officer change
14 Nov 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
16 Aug 2022Sharp changeMany funds opening a new position: many funds opening a new position, 46 vs usual 21.50 (2022-06-30); 3.3x the same period a year earlier
6 Jun 20228-K and other filingsDirector or officer change
23 May 20228-K and other filingsDirector or officer change
10 May 2022Sharp changeQuarterly revenue change: quarterly revenue change, 365.6M vs usual 276.1M (2022-03-31); 1.3x the same period a year earlier
18 Apr 20228-K and other filingsDirector or officer change
18 Apr 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
10 Mar 20228-K and other filingsCompleted an acquisition or asset sale
15 Feb 2022Sharp changeQuarterly revenue change: quarterly revenue change, 371.2M vs usual 269.9M (2021-12-31); 1.3x the same period a year earlier
Insider net buying (open market)
Month from 1 Dec 2021: $1K published
Month from 1 Feb 2022: $1.5M published
Month from 1 May 2022: -$75K published
Month from 1 Jun 2022: $317K published
Month from 1 Sep 2022: -$99K published
Month from 1 Nov 2022: -$3.2M published
Month from 1 Dec 2022: -$103K published
Month from 1 May 2023: -$4.2M published
Month from 1 Aug 2023: -$127K published
Month from 1 Nov 2023: -$20.0M published
Month from 1 Dec 2023: -$285K published
Month from 1 May 2024: -$62K published
Month from 1 Aug 2024: -$9.5M published
Month from 1 Sep 2024: -$14.5M published
Month from 1 Dec 2024: -$362K published
Month from 1 Feb 2025: -$1.5M published
Month from 1 Mar 2025: $87K published
Month from 1 May 2025: -$127K published
Month from 1 Jun 2025: -$294K published
Month from 1 Aug 2025: -$7.7M published
Month from 1 Nov 2025: $142K published
Month from 1 Mar 2026: $3.8M published
Month from 1 May 2026: -$4.8M published
Month from 1 Jun 2026: -$690K published
Month from 1 Jul 2026: -$2.1M published
Month from 1 Aug 2026: -$1.6M published
Month from 1 Oct 2026: -$1.1M published
H-1B/E-3 applications certified
Quarter from 1 Jul 2026: 3 published
Quarter from 1 Oct 2026: 5 published
Revenue per quarter
Quarter ended 30 Jun 2021: $223.5M; public on 12 Aug 2022
Quarter ended 31 Dec 2021: $371.2M, +31% on a year earlier; public on 9 Feb 2022
Quarter ended 31 Mar 2022: $365.6M, +30% on a year earlier; public on 6 May 2022
Quarter ended 30 Jun 2022: $361.2M, +62% on a year earlier; public on 12 Aug 2022
Quarter ended 30 Sep 2022: $354.6M, +1.8% on a year earlier; public on 4 Nov 2022
Quarter ended 31 Dec 2022: $363.3M, -2.1% on a year earlier; public on 3 Feb 2023
Quarter ended 31 Mar 2023: $369.1M, +0.9% on a year earlier; public on 3 May 2023
Quarter ended 30 Sep 2023: $368.8M, +4.0% on a year earlier; public on 27 Oct 2023
Quarter ended 31 Dec 2023: $393.2M, +8.2% on a year earlier; public on 31 Jan 2024
Quarter ended 31 Mar 2024: $412.7M, +12% on a year earlier; public on 3 May 2024
Quarter ended 30 Jun 2024: $409.9M; public on 7 Aug 2024
Quarter ended 30 Sep 2024: $417.4M, +13% on a year earlier; public on 30 Oct 2024
Quarter ended 31 Dec 2024: $447.7M, +14% on a year earlier; public on 31 Jan 2025
Quarter ended 31 Mar 2025: $466.1M, +13% on a year earlier; public on 9 May 2025
Quarter ended 30 Jun 2025: $457.1M, +12% on a year earlier; public on 8 Aug 2025
Quarter ended 30 Sep 2025: $462.3M, +11% on a year earlier; public on 31 Oct 2025
Quarter ended 31 Dec 2025: $503.4M, +12% on a year earlier; public on 29 Jan 2026
Quarter ended 31 Mar 2026: $487.0M, +4.5% on a year earlier; public on 8 May 2026
Quarter ended 30 Jun 2026: $501.4M, +9.7% on a year earlier; public on 7 Aug 2026
Quarter ended 30 Sep 2026: $511.5M, +11% on a year earlier; public on 30 Oct 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $8.1M, -17% on a year earlier; public on 9 Feb 2022
Quarter ended 31 Mar 2022: $7.5M, -30% on a year earlier; public on 6 May 2022
Quarter ended 30 Sep 2022: $5.6M, -24% on a year earlier; public on 4 Nov 2022
Quarter ended 31 Dec 2022: $4.2M, -48% on a year earlier; public on 3 Feb 2023
Quarter ended 31 Mar 2023: $9.3M, +25% on a year earlier; public on 3 May 2023
Quarter ended 30 Sep 2023: $15.0M, +171% on a year earlier; public on 27 Oct 2023
Quarter ended 31 Dec 2023: $15.3M, +264% on a year earlier; public on 31 Jan 2024
Quarter ended 31 Mar 2024: $21.7M, +133% on a year earlier; public on 3 May 2024
Quarter ended 30 Jun 2024: $16.6M; public on 7 Aug 2024
Quarter ended 30 Sep 2024: $10.4M, -31% on a year earlier; public on 30 Oct 2024
Quarter ended 30 Sep 2025: $16.0M, +54% on a year earlier; public on 31 Oct 2025
Quarter ended 31 Dec 2025: $14.6M; public on 29 Jan 2026
Quarter ended 31 Mar 2026: $20.2M; public on 8 May 2026
Quarter ended 30 Jun 2026: $26.8M; public on 7 Aug 2026
Quarter ended 30 Sep 2026: $37.6M, +135% on a year earlier; public on 30 Oct 2026
Institutional holders (13F filers)
31 Dec 2021 report: 156; public on 14 Feb 2022
31 Mar 2022 report: 161; public on 16 May 2022
30 Jun 2022 report: 187; public on 15 Aug 2022
30 Sep 2022 report: 160; public on 14 Nov 2022
31 Dec 2022 report: 191; public on 14 Feb 2023
31 Mar 2023 report: 180; public on 15 May 2023
30 Jun 2023 report: 181; public on 14 Aug 2023
30 Sep 2023 report: 191; public on 14 Nov 2023
31 Dec 2023 report: 228; public on 14 Feb 2024
31 Mar 2024 report: 231; public on 15 May 2024
30 Jun 2024 report: 248; public on 14 Aug 2024
30 Sep 2024 report: 260; public on 14 Nov 2024
31 Dec 2024 report: 304; public on 14 Feb 2025
31 Mar 2025 report: 324; public on 15 May 2025
30 Jun 2025 report: 367; public on 14 Aug 2025
30 Sep 2025 report: 380; public on 14 Nov 2025
31 Dec 2025 report: 353; public on 17 Feb 2026
31 Mar 2026 report: 343; public on 15 May 2026
30 Jun 2026 report: 369; public on 14 Aug 2026
30 Sep 2026 report: 385; public on 16 Nov 2026
Federal obligations
Month from 1 Dec 2021: $123K published
Month from 1 Jan 2022: $14K published
Month from 1 Feb 2022: $18K published
Month from 1 Mar 2022: $10K published
Month from 1 Apr 2022: $31K published
Month from 1 May 2022: $245K published
Month from 1 Jun 2022: $52K published
Month from 1 Jul 2022: $1.4M published
Month from 1 Aug 2022: $65K published
Month from 1 Sep 2022: $430K published
Month from 1 Nov 2022: $92K published
Month from 1 Dec 2022: $134K published
Month from 1 Feb 2023: $56K published
Month from 1 Mar 2023: $18K published
Month from 1 May 2023: $254K published
Month from 1 Jun 2023: $13K published
Month from 1 Jul 2023: $331K published
Month from 1 Sep 2023: $86K published
Month from 1 Nov 2023: $16K published
Month from 1 Dec 2023: $24K published
Month from 1 Mar 2024: $11K published
Month from 1 Apr 2024: $15K published
Month from 1 Jun 2024: $1.2M published
Month from 1 Jul 2024: $0 published
Month from 1 Oct 2024: $0 published
Month from 1 Nov 2024: $0 published
Month from 1 Mar 2025: $11K published
Month from 1 Apr 2025: $15K published
Month from 1 Jun 2025: $2K published
Month from 1 Aug 2025: $0 published
Month from 1 Sep 2025: $21K published
Month from 1 Dec 2025: $14K published
Month from 1 Mar 2026: -$11K published
Month from 1 Apr 2026: $15K published
Month from 1 May 2026: $0 published
Month from 1 Jun 2026: $2K published
Month from 1 Sep 2026: $14K published
Month from 1 Oct 2026: $34K published
Month from 1 Nov 2026: $0 published
Lobbying spend
Quarter from 1 Jan 2022: $120K published
Quarter from 1 Apr 2022: $110K published
Quarter from 1 Jul 2022: $100K published
Quarter from 1 Oct 2022: $120K published
Quarter from 1 Jan 2023: $90K published
Quarter from 1 Apr 2023: $60K published
Quarter from 1 Jul 2023: $50K published
Quarter from 1 Oct 2023: $300K published
Quarter from 1 Jan 2024: $150K published
Quarter from 1 Apr 2024: $150K published
Quarter from 1 Jul 2024: $140K published
Quarter from 1 Oct 2024: $530K published
Quarter from 1 Jan 2025: $170K published
Quarter from 1 Apr 2025: $160K published
Quarter from 1 Jul 2025: $310K published
Quarter from 1 Oct 2025: $950K published
Quarter from 1 Jan 2026: $240K published
Quarter from 1 Apr 2026: $220K published
Quarter from 1 Jul 2026: $160K published
Quarter from 1 Oct 2026: $120K published

What is unusual now

  • Made public in the last 90 days: it spent $37.6M on capital projects in the quarter ended 30 Sep 2026, 2.3× the same quarter last year.
  • Quarterly capital spending jump: spent $37.6M on capital projects in the quarter ended 30 Sep 2026, 2.3× the same quarter last year Public on 3 Nov 2026.
  • Insider net buying (open market): Insiders sold a net $6.6M in the last 12 months (the 12 months before: -$9.7M).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 8 published in the last 12 months (none in the 12 months before).

Latest records

The names and amounts behind the totals, newest first

Last 90 days: 2 sales, $1.3M; no purchases. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
9 Oct 2026Stephen W. BeardChairman & CEOSellplanned in advance (10b5-1)8,306$130.59$1.1MForm 4
28 Aug 2026Manjunath GangadharanVP, Chief Accounting OfficerSellplanned in advance (10b5-1)1,802$137.18$247KForm 4
13 Aug 2026Stephen W. BeardChairman & CEOSellplanned in advance (10b5-1)3,545$130.35$462KForm 4
11 Aug 2026Robert J. PhelanChief Financial OfficerSellplanned in advance (10b5-1)2,186$135.15$295KForm 4
11 Aug 2026Douglas G. BeckSVP, GC, Corp. Sec & ISSSellplanned in advance (10b5-1)4,526$135.81$615KForm 4
15 Jul 2026Stephen W. BeardChairman & CEOSellplanned in advance (10b5-1)5,291$132.75$702KForm 4
9 Jul 2026Douglas G. BeckSVP, GC, Corp. Sec & ISSSellplanned in advance (10b5-1)5,089$135.37$689KForm 4
9 Jul 2026Robert J. PhelanChief Financial OfficerSellplanned in advance (10b5-1)5,314$135.40$720KForm 4

385 institutions reported shares at the end of Q3 2026, 100% of the shares outstanding; 53 opened a position, 36 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.5.1M15.5%$628.7M-335K-6.1%
FMR LLC (Fidelity)4.3M12.9%$523.9M+1.1M+33%
Vanguard Portfolio Management LLC2.3M6.82%$277.3M-117K-4.9%
Dimensional Fund Advisors LP1.9M5.58%$226.7M+72K+4.1%
Ariel Investments, LLC1.6M4.94%$200.9M-128K-7.2%
Vanguard Capital Management LLC1.5M4.44%$180.3M+1,569+0.1%
State Street Corp1.4M4.13%$168.0M-15K-1.1%
Capital World Investors941K2.83%$115.0M-123K-12%
Geode Capital Management, LLC882K2.65%$107.8M-12K-1.4%
T. Rowe Price Associates Inc788K2.37%+20K+2.6%

Federal contracts

All 9 federal contracts

No new award in 12 months; the latest was signed 12 Mar 2021. New awards only; later changes to an award are not listed.

SignedAgencyAmountWhat forSource
12 Mar 2021Department of Education$4.9MCARRINGTON COLLEGE SACRAMENTO CRRSSA STUDENT GRANT APPLICATIONGrantUSAspending
12 Mar 2021Department of Education$3.7MCARRINGTON COLLEGE PHOENIX CRRSSA STUDENT GRANT APPLICATIONGrantUSAspending
17 Feb 2021Department of Education$11.8MCRSAA - HEERF II PROPRIETARY INSTITUTION GRANT FUNDS FOR STUDENTSGrantUSAspending
25 Jun 2020Department of Education$4.0MCARES ACT HIGHER EDUCATION EMERGENCY RELIEF FUND- INSTITUTIONAL ALLOCATION FOR CHAMBERLAIN UNIVERSITY OPEID 00638500.GrantUSAspending
17 Jun 2020Department of Education$4.0MCARES ACT HIGHER EDUCATION EMERGENCY RELIEF FUND- STUDENT AWARDS ALLOCATION FOR CHAMBERLAIN UNIVERSITY OPEID 00638500.GrantUSAspending
6 May 2020Department of Education$2.7MCARRINGTON COLLEGE CARES ACT HIGHER EDUCATION EMERGENCY RELIEF FUND APPLICATION INSTITUTIONAL SHAREGrantUSAspending
6 May 2020Department of Education$1.9MCARRINGTON COLLEGE PHOENIX CARES ACT HIGHER EDUCATION EMERGENCY FUND INSTITUTION DISBURSEMENTGrantUSAspending
25 Apr 2020Department of Education$1.9MCARRINGTON COLLEGE AZ CARES ACT GRANT CERTIFICATION STUDENT HALFGrantUSAspending

Company events

All 65 company events

In 12 months: 2 major agreements, 1 agreement ended, 1 director or officer change. Results releases and routine reports are left out.

FiledWhat happenedSource
23 Sep 2026Signed a major agreementSame filing: took on new debt8-K
28 Jul 2026Director or officer change8-K
3 Mar 2026Signed a major agreement; A major agreement endedSame filing: took on new debt8-K
7 Aug 2025Signed a major agreementSame filing: took on new debt8-K
19 Nov 2024Director or officer changeSame filing: shareholder vote results8-K
9 Jan 2024Director or officer change8-K
6 Sep 2023Director or officer change8-K
14 Nov 2022Director or officer changeSame filing: shareholder vote results8-K

Reported lobbying spend: $120K in Q3 2026, $160K in Q2 2026. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
14 Jun 2026EndedAlpine Group Partners, LLC.for CovistaEducation, student loans, Department of Education, medical workforce shortageEducation, Labor, Health issuesFiling
1 May 2026EndedFerox Strategiesfor Covista (Formerly Known As Adtalem Global Education)General issues related to for-profit higher education.Budget, Education, Health issues, TaxationFiling
1 May 2025NewFerox Strategiesfor Covista (Formerly Known As Adtalem Global Education)General issues related to higher education.Education, Health issues, Taxation, BudgetFiling
15 May 2024NewAlpine Group Partners, LLC.for CovistaEducation, student loans, Department of Education, medical workforce shortageEducation, Labor, Health issuesFiling
15 Aug 2023NewThegroup DC, LLCfor CovistaGeneral issues related to education of the healthcare workforce.EducationFiling
31 Oct 2019EndedDentons US LLPfor Adtalem Global Education (Formerly Devry Education Group)Not statedFiling
3 Jul 2017NewCovista Inc.its own lobbyistsReauthorization of the Higher Education Act; Regulations of the Department of Education regarding Title IV programs of the HEA.EducationFiling
30 Jun 2017EndedMoevela LLCfor Devry Education Group Inc.Higher Education, For-Profit CollegesEducationFiling

The 5 newest of 75 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

13 Nov 2021confirmed

Confirmed across sources Insiders and Lobbying

Covista (CVSA): reported $320K of lobbying spend for the quarter ended 30 Sep 2021, 2.7× the same quarter last year, while it had 3 insiders buy $744K of its shares on the open market within 30 days (3 filings). Two unrelated kinds of activity within 17 days.

  • Lobbying: Lobbying spend jump, became public on 20 Oct 2021
  • Insiders: Clustered insider buying, became public on 13 Nov 2021
2019-09-30: $240K2019-12-31: $100K2020-03-31: $110K2020-06-30: $80K2020-09-30: $120K2020-12-31: $90K2021-03-31: $100K2021-06-30: $110K2021-09-30: $320K
The quarter ended 30 Sep 2021 against the 8 quarters before it. this quarterearliernormal: $105K
See the evidence (2 changes)

Lobbying: Lobbying spend jump became public on 20 Oct 2021

Covista reported $320K of lobbying spend for the quarter ended 30 Sep 2021, 2.7× the same quarter last year.

This period
$320K (the quarter ended 30 Sep 2021)
Normal quarter (median of 8 earlier)
$105K
Typical spread (median absolute deviation)
$10K
How far from its usual level
+10.8
Same quarter last year
$120K
History used
3,105 days
2019-09-30: $240K2019-12-31: $100K2020-03-31: $110K2020-06-30: $80K2020-09-30: $120K2020-12-31: $90K2021-03-31: $100K2021-06-30: $110K2021-09-30: $320K
the quarter ended 30 Sep 20218 earlier quartersnormal: $105K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.

Check it at the source: Senate/House lobbying disclosures (LDA).

Insiders: Clustered insider buying became public on 13 Nov 2021

Covista had 3 insiders buy $744K of its shares on the open market within 30 days (3 filings).

Independent buyers
3
Purchase filings (Form 4, code P)
3
Total bought
$744K
Window
14 Oct 2021 to 13 Nov 2021

Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

20 Jul 2021confirmed

Confirmed across sources Government contracts and Lobbying

Covista (CVSA): lobbying on a new issue, while it booked $5.8M in federal contract and grant obligations in June 2021, 23% below the same month last year. Two unrelated kinds of activity on the same day.

  • Lobbying: Lobbying on a new issue, became public on 20 Jul 2021
  • Government contracts: Federal obligations jump, became public on 15 Jul 2021
2016-06-01: $19K2017-06-01: $25K2018-06-01: $02019-06-01: $02020-06-01: $7.6M2021-06-01: $5.8M
June 2021 against the 5 months before it. this monthearliernormal: $19K
See the evidence (2 changes)

Lobbying: Lobbying on a new issue became public on 20 Jul 2021

Covista lobbying on a new issue.

New
['TAX']
Rule
only points whose every posting (and value revision) is at or before as_of
Field
issue_codes
Metric
lobbying.filings_count
Point id
12638687

Government contracts: Federal obligations jump became public on 15 Jul 2021

Covista booked $5.8M in federal contract and grant obligations in June 2021, 23% below the same month last year.

This period
$5.8M (June 2021)
Normal month (median of 5 earlier)
$19K
Typical spread (median absolute deviation)
$19K
How far from its usual level
+5.8
Same month last year
$7.6M
History used
5,020 days
2016-06-01: $19K2017-06-01: $25K2018-06-01: $02019-06-01: $02020-06-01: $7.6M2021-06-01: $5.8M
June 20215 earlier monthsnormal: $19K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.

Check it at the source: USAspending.gov award search.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 3 Nov 2026Financials change

    spent $37.6M on capital projects in the quarter ended 30 Sep 2026, 2.3× the same quarter last year.

    Same quarter last year: $16.0M; its normal quarter is $16.3M.

    See the evidence
    This period
    $37.6M (the quarter ended 30 Sep 2026)
    Normal quarter (median of 8 earlier)
    $16.3M
    Typical spread (median absolute deviation)
    $2.8M
    How far from its usual level
    +5.1
    Same quarter last year
    $16.0M
    History used
    6,209 days
    2023-12-31: $15.3M2024-03-31: $21.7M2024-06-30: $16.6M2024-09-30: $10.4M2025-09-30: $16.0M2025-12-31: $14.6M2026-03-31: $20.2M2026-06-30: $26.8M2026-09-30: $37.6M
    the quarter ended 30 Sep 20268 earlier quartersnormal: $16.3M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  2. 28 Jul 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  3. 28 Jul 2026Filings record

    Director or officer change

  4. 21 Jul 2026Lobbying record

    COVISTA: lobbying engagement terminated (ALPINE GROUP PARTNERS, LLC.) (dated 14 Jun 2026)

  5. 20 Jul 2026Lobbying record

    COVISTA (FORMERLY KNOWN AS ADTALEM GLOBAL EDUCATION): lobbying engagement terminated (FEROX STRATEGIES) (dated 1 May 2026)

  6. 13 Mar 2026Insiders record

    MALAFRONTE MICHAEL W (Lead Independent Director) bought 36,036 shares of CVSA ($3.6M) (dated 12 Mar 2026)

  7. 6 Mar 2026Insiders record

    MALAFRONTE MICHAEL W (Lead Independent Director) bought 1,200 shares of CVSA ($117,564) (dated 5 Mar 2026)

  8. 3 Mar 2026Filings record

    A major agreement ended

  9. 6 Nov 2025Insiders record

    Phelan Kenneth J (director) bought 508 shares of ATGE ($49,931) (dated 5 Nov 2025)

  10. 5 Nov 2025Insiders record

    MALAFRONTE MICHAEL W (Lead Independent Director) bought 1,000 shares of ATGE ($91,850) (dated 4 Nov 2025)

  11. 30 Jun 2025Lobbying record

    COVISTA (FORMERLY KNOWN AS ADTALEM GLOBAL EDUCATION): new lobbying registration (FEROX STRATEGIES) (dated 1 May 2025)

  12. 8 Mar 2025Insiders record

    MALAFRONTE MICHAEL W (Lead Independent Director) bought 1,000 shares of ATGE ($87,210) (dated 7 Mar 2025)

  13. 19 Nov 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  14. 19 Nov 2024Filings record

    Director or officer change

  15. 22 Oct 2024Lobbying change

    reported $530K of lobbying spend for the quarter ended 30 Sep 2024, 1.8× the same quarter last year.

    Same quarter last year: $300K; its normal quarter is $130K.

    See the evidence
    This period
    $530K (the quarter ended 30 Sep 2024)
    Normal quarter (median of 8 earlier)
    $130K
    Typical spread (median absolute deviation)
    $30K
    How far from its usual level
    +9.0
    Same quarter last year
    $300K
    History used
    4,201 days
    2022-09-30: $120K2022-12-31: $90K2023-03-31: $60K2023-06-30: $50K2023-09-30: $300K2023-12-31: $150K2024-03-31: $150K2024-06-30: $140K2024-09-30: $530K
    the quarter ended 30 Sep 20248 earlier quartersnormal: $130K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.

    Check it at the source: Senate/House lobbying disclosures (LDA).

  16. 28 Jun 2024Lobbying record

    COVISTA: new lobbying registration (ALPINE GROUP PARTNERS, LLC.) (dated 15 May 2024)

  17. 7 May 2024Financials change

    spent $21.7M on capital projects in the quarter ended 31 Mar 2024, 2.3× the same quarter last year.

    Same quarter last year: $9.3M; its normal quarter is $7.8M.

    See the evidence
    This period
    $21.7M (the quarter ended 31 Mar 2024)
    Normal quarter (median of 8 earlier)
    $7.8M
    Typical spread (median absolute deviation)
    $1.9M
    How far from its usual level
    +5.0
    Same quarter last year
    $9.3M
    History used
    5,296 days
    2021-09-30: $7.3M2021-12-31: $8.1M2022-03-31: $7.5M2022-09-30: $5.6M2022-12-31: $4.2M2023-03-31: $9.3M2023-09-30: $15.0M2023-12-31: $15.3M2024-03-31: $21.7M
    the quarter ended 31 Mar 20248 earlier quartersnormal: $7.8M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  18. 9 Jan 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  19. 9 Jan 2024Filings record

    Director or officer change

  20. 20 Oct 2023Lobbying change

    reported $300K of lobbying spend for the quarter ended 30 Sep 2023, 2.5× the same quarter last year.

    Same quarter last year: $120K; its normal quarter is $105K.

    See the evidence
    This period
    $300K (the quarter ended 30 Sep 2023)
    Normal quarter (median of 8 earlier)
    $105K
    Typical spread (median absolute deviation)
    $15K
    How far from its usual level
    +8.8
    Same quarter last year
    $120K
    History used
    3,835 days
    2021-09-30: $320K2021-12-31: $120K2022-03-31: $110K2022-06-30: $100K2022-09-30: $120K2022-12-31: $90K2023-03-31: $60K2023-06-30: $50K2023-09-30: $300K
    the quarter ended 30 Sep 20238 earlier quartersnormal: $105K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.

    Check it at the source: Senate/House lobbying disclosures (LDA).

  21. 6 Sep 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  22. 6 Sep 2023Filings record

    Director or officer change

  23. 5 Sep 2023Lobbying record

    COVISTA: new lobbying registration (THEGROUP DC, LLC) (dated 15 Aug 2023)

  24. 20 Apr 2023Lobbying change

    lobbying on a new issue.

    See the evidence
    New
    ['AGR']
    Rule
    only points whose every posting (and value revision) is at or before as_of
    Field
    issue_codes
    Metric
    lobbying.filings_count
    Point id
    12623277
  25. 14 Nov 2022Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  26. 14 Nov 2022Filings record

    Director or officer change

  27. 15 Aug 2022Institutional holdings change

    saw 46 13F filers open a new position in the quarter ended 30 Jun 2022, 3.3× the same quarter last year.

    Same quarter last year: 14; its normal quarter is 21.5.

    See the evidence
    This period
    46 (the quarter ended 30 Jun 2022)
    Normal quarter (median of 8 earlier)
    21.5
    Typical spread (median absolute deviation)
    4
    How far from its usual level
    +4.1
    Same quarter last year
    14
    History used
    1,826 days
    2020-06-30: 432020-09-30: 222020-12-31: 182021-03-31: 312021-06-30: 142021-09-30: 262021-12-31: 202022-03-31: 212022-06-30: 46
    the quarter ended 30 Jun 20228 earlier quartersnormal: 21.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  28. 16 Jun 2022Insiders record

    Krehbiel William V (director) bought 10,000 shares of ATGE ($316,700) (dated 15 Jun 2022)

  29. 6 Jun 2022Filings record

    Director or officer change

  30. 23 May 2022Filings record

    Director or officer change

  31. 10 May 2022Financials change

    reported revenue of $365.6M for the quarter ended 31 Mar 2022, 1.3× the same quarter last year.

    Same quarter last year: $280.7M; its normal quarter is $276.1M.

    See the evidence
    This period
    $365.6M (the quarter ended 31 Mar 2022)
    Normal quarter (median of 8 earlier)
    $276.1M
    Typical spread (median absolute deviation)
    $8.9M
    How far from its usual level
    +3.2
    Same quarter last year
    $280.7M
    History used
    4,565 days
    2019-12-31: $266.2M2020-03-31: $271.5M2020-06-30: $259.7M2020-09-30: $268.2M2020-12-31: $283.1M2021-03-31: $280.7M2021-09-30: $348.3M2021-12-31: $371.2M2022-03-31: $365.6M
    the quarter ended 31 Mar 20228 earlier quartersnormal: $276.1M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  32. 18 Apr 2022Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  33. 18 Apr 2022Filings record

    Director or officer change

  34. 10 Mar 2022Filings record

    Completed an acquisition or asset sale

  35. 24 Feb 2022Insiders record

    O'KEEFE SHARON (director) bought 1,250 shares of ATGE ($25,788) (dated 23 Feb 2022)

  36. 18 Feb 2022Insiders record

    DeShazer Charles (director) bought 500 shares of ATGE ($10,325) (dated 17 Feb 2022)

  37. 18 Feb 2022Insiders record

    Hrinak Donna J (director) bought 415 shares of ATGE ($9,997) (dated 17 Feb 2022)

  38. 15 Feb 2022Financials change

    reported revenue of $371.2M for the quarter ended 31 Dec 2021, 1.3× the same quarter last year.

    Same quarter last year: $283.1M; its normal quarter is $269.9M.

    See the evidence
    This period
    $371.2M (the quarter ended 31 Dec 2021)
    Normal quarter (median of 8 earlier)
    $269.9M
    Typical spread (median absolute deviation)
    $10.5M
    How far from its usual level
    +3.8
    Same quarter last year
    $283.1M
    History used
    4,475 days
    2019-09-30: $254.6M2019-12-31: $266.2M2020-03-31: $271.5M2020-06-30: $259.7M2020-09-30: $268.2M2020-12-31: $283.1M2021-03-31: $280.7M2021-09-30: $348.3M2021-12-31: $371.2M
    the quarter ended 31 Dec 20218 earlier quartersnormal: $269.9M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  39. 15 Feb 2022Insiders record

    Logan Lyle (director) bought 1,625 shares of ATGE ($40,000) (dated 14 Feb 2022)

  40. 15 Feb 2022Insiders record

    MALAFRONTE MICHAEL W (director) bought 40,500 shares of ATGE ($954,990) (dated 14 Feb 2022)

Showing the newest 40 of 130 entries; narrow the window or the kind of data to see older ones.

Not listed: 268 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0000730464
Ticker
CVSA
Domain
covista.com
Employer name
Adtalem Global Education Inc., Covista Inc. (2 unverified)
Fein
36-3150143 (1 unverified)
Hq location
IL|CHICAGO|60606 (1 unverified)
Lobbying client
adtalem global education formerly devry education group, covista, covista formerly known as adtalem global education, devry education group
Name
Adtalem Global Education Inc., Covista Inc., DEVRY EDUCATION GROUP INC., DEVRY INC and 1 more
Uei
K3MWSYEG32U5
Wikidata
Q5244154
Wikipedia
Covista
  • DOL H-1B labor condition applications and PERM certifications32 data points8 Dec 2025 to 14 Sep 2026
  • Federal lobbying disclosures (LDA)11 records, 165 data points1 Mar 2013 to 30 Sep 2026
  • SEC Form 13F institutional holdings342 data points30 Jun 2017 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)180 records4 Feb 2016 to 29 Oct 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)1062 data points30 Jun 2008 to 23 Oct 2026
  • SEC Form 4 insider transactions165 records, 520 data points25 Feb 2016 to 9 Oct 2026
  • FINRA short interest (twice monthly)51 data points27 Feb 2026 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)378 data points24 Feb 2026 to 20 Nov 2026
  • USASpending.gov federal awards9 records, 841 data points2 Oct 2007 to 4 Nov 2026
  • Wikipedia pageviews251 data points16 Mar 2026 to 21 Nov 2026